PetCaseFinder

Peer-reviewed veterinary case report

Enoxolone pharmacokinetics, tissue distribution, and residue depletion in largemouth bass (Micropterus salmoides).

Journal:
BMC veterinary research
Year:
2025
Authors:
Li, Chen et al.
Affiliation:
Department of Aquaculture · China

Abstract

UNLABELLED: Enoxolone, a hydrolyzed component of Chinese herbal medicine, has shown efficacy againstin largemouth bass (). However, its pharmacokinetics and muscle residue depletion inare not well understood. This study analyzed plasma and tissue samples using High-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) after exposure to 16 mg/L enoxolone. Results indicated a bimodal plasma absorption pattern, with the first peak at 2 h and the highest concentration (C= 44.67 mg/L) at 24 h. The plasma AUCwas 813.40 mg·h/L, and the MRT was 36 h. Significant accumulation occurred in the kidneys (C= 2223.33 mg/kg, AUC= 7268.967 mg·h/L) which is more than other organs. But the T(72 h) and MRT (51 h) is the longest. Muscle residues declined to 0.0164 mg/kg by day 11 post-immersion and the withdrawal time is at least 15 d. Enoxolone concentrations in plasma and tissues reached the MIC within 4–8 h. Acute toxicity tests showed a 96 h LCof 12.17 mg/L, with no mortality at concentrations ≤ 50 mg/L within 24 h. Based on these findings, a 4 h immersion at 16 mg/L is recommended for effectivecontrol, followed by an 15 d withdrawal period to meet food safety standards. This study offers crucial data for optimizing enoxolone use in aquaculture. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12917-025-04981-9.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication: https://pubmed.ncbi.nlm.nih.gov/40993708/